By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BrainStorm Cell Therapeutics Inc. 

Tel Aviv      Israel
Phone: n/a Fax:



Company News
BrainStorm Cell Reports On Successful End Of Phase 2 Meeting With FDA, Upcoming Phase 3 Trial And Planned Application For Hospital Exemption For NurOwn 12/19/2016 8:28:44 AM
BrainStorm Cell Release: In-Depth Analyses Presented At International Symposium On ALS/MND Suggest Strong Biological Effect For NurOwn; Evidence Of Halting Of Disease Progression 12/14/2016 6:55:48 AM
BrainStorm Cell Reports Third Quarter 2016 Financial Results 11/15/2016 10:50:46 AM
BrainStorm Cell Granted United States Patent For Its Stem Cell Technology 10/31/2016 6:52:30 AM
BrainStorm Cell CEO To Present At Two Investor Conferences In September 9/6/2016 1:11:46 PM
BrainStorm Cell Reports Second Quarter 2016 Financial Results And Provides Corporate Update 8/11/2016 9:52:51 AM
BrainStorm Cell Announces Positive Top Line Results From The U.S. Phase 2 Study Of NurOwn In Patients With Amyotrophic Lateral Sclerosis (ALS) 7/18/2016 7:35:01 AM
BrainStorm Cell To Announce Top Line Results From The U.S. Phase 2 Study of NurOwn In Patients With Amyotrophic Lateral Sclerosis (ALS) On Monday, July 18 7/15/2016 6:09:46 AM
BrainStorm Cell To Present At World Stem Cells & Regenerative Medicine Congress In London 5/17/2016 8:07:54 AM
BrainStorm Cell Awarded $1.5 Million Non-Dilutive Grant For 2016 From Israel's Office Of The Chief Scientist 5/12/2016 6:36:27 AM